Prostatic carcinoma: a multivariate analysis of prognostic factors

Area of Science:

• Oncology
• Pathology
• Biomarkers

Background:

• Prognostic factors for prostate cancer are crucial for treatment decisions.
• Histological grading and specific protein expressions are potential indicators of disease progression.

Purpose of the Study:

• To evaluate the prognostic value of various histological and immunohistochemical markers in prostate cancer.
• To identify independent predictors of survival in patients with localized and metastatic prostate cancer.

Main Methods:

• Analysis of tissue specimens from 266 prostate cancer patients (150 localized, 116 metastatic).
• Assessment of histological grade (WHO, Gleason) and immunohistochemical markers (PAP, PSA, NSE, p53, c-erbB-2, cytokeratins, vimentin).
• Multivariate regression analysis stratified by metastatic status.

Main Results:

• WHO grading was the strongest independent prognosticator, followed by age and prostate acid phosphatase (PAP) expression.
• Decreasing prostate-specific antigen (PSA) reactivity showed a trend towards reduced survival.
• Gleason grading demonstrated poor prognostic ability; extensive neurone-specific enolase (NSE) reactivity predicted reduced survival.

Conclusions:

• WHO grading, patient age, and PAP expression are significant independent prognostic factors in prostate cancer.
• PSA reactivity may have a role in predicting survival, warranting further investigation.
• The Gleason system and NSE reactivity require careful interpretation in prostate cancer prognostication.